Project Grant R34DA063088
Award Date
7/15/25
Completion Date
6/30/28
Dollars Obligated
$743K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $425,636 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct patient-oriented substance use and smoking cessation research in the context of HIV treatment and prevention. The key activities funded under this 5-year award include: 1) Mentoring junior researchers (pre- and post-doctoral fellows,...
The National Institute on Drug Abuse (NIDA) awarded a $1,076,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dynamicare Health Inc. in Wareham, MA. The award will fund a Phase II randomized clinical trial to evaluate the efficacy of DCH-003, a digital therapeutic that delivers contingency management for the treatment of stimulant use disorder. The trial will compare standard clinic care plus DCH-003 to standard care plus a sham digital app, with the...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), has awarded a $197,640 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct a pilot randomized controlled trial of a digital therapeutic called AMP-C. The goal of AMP-C is to address the co-occurring conditions of cannabis use disorder (CUD) and major depressive disorder (MDD) by targeting reward dysfunction, a...
The federal Project Grant award R01DA061841, totaling $823,882.00, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports the "TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care" project, which aims to implement and evaluate two outreach strategies - a predominately person-based outreach navigator (ON) and a technology-based interactive patient portal (IPP) - to improve the delivery of...
The National Institute on Drug Abuse (NIDA) awarded a $306,528 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Addinex Technologies, Inc. The grant will fund the development of a medication adherence and monitoring system to support decentralized clinical trials for substance use disorder (SUD). The project aims to adapt Addinex's existing medication management system to provide researchers running SUD clinical trials with a tool for at-home dispensing that...
This Cooperative Agreement award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and validate a novel patient-reported outcome measure of substance-related consequences for use in substance use disorder (SUD) treatment trials. The $352,064 award, effective from August 1, 2025 to July 31, 2027, will be executed by the Mclean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with...
The National Institute on Drug Abuse (NIDA) awarded a $326,410 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Berkshire Biomedical Corporation in Dallas, TX. The grant will fund a two-phased clinical study to evaluate the feasibility, acceptance, and impact on treatment retention of a hand-held, automated, personalized oral liquid dispensing system (COPA) for delivering take-home methadone to patients with opioid use disorder. The initial single-site pilot...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is intended to develop and evaluate the efficacy of a universal overdose prevention intervention to be delivered in primary care settings. The $2,467,574 award will fund a pilot two-arm cluster randomized controlled trial at Boston Medical Center to assess the acceptability and feasibility of the intervention for providers and youth ages 13-26. The...
The National Institute on Drug Abuse (NIDA) awarded a $863,837 Project Grant under CFDA 93.279 (Drug Use and Addiction Research Programs) to the National Opinion Research Center (NORC) to study the effects of alternative tobacco product marketing on social media platforms like Instagram, Facebook, and TikTok, and its impact on tobacco use among youth and young adults. The project aims to: 1) identify and characterize social media content related to alternative tobacco products, 2) assess the...
The National Institute on Drug Abuse (NIDA) awarded a $445,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant will fund the development and pilot testing of a novel telehealth and mobile health intervention called MOMENT-V to address cannabis use disorder in young adults seen in primary care. The intervention combines motivational enhancement therapy delivered via...